Blood protein may spot hidden pregnancy danger

NCT ID NCT07421180

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a substance in the blood called adropin can help identify placenta accreta spectrum, a serious condition where the placenta grows too deeply into the womb. Researchers measured adropin levels in 84 pregnant women—42 with the condition and 42 healthy—to see if it could serve as a diagnostic marker. The goal is to find a simple blood test that could warn doctors early, improving safety for mothers and babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLACENTA ACCRETA SPECTRUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Heath and Science Adana City Hospital

    Adana, Yuregir, 01100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.